CID 16073757
3-quinolinecarboxylic acid, 7-[4-[(5-amino-1,3,4-thiadiazol-2-yl)sulfonyl]-3-methyl-1-piperazinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-
Structural Information
- Molecular Formula
- C21H23FN6O6S2
- SMILES
- CC1CN(CCN1S(=O)(=O)C2=NN=C(S2)N)C3=C(C=C4C(=C3OC)N(C=C(C4=O)C(=O)O)C5CC5)F
- InChI
- InChI=1S/C21H23FN6O6S2/c1-10-8-26(5-6-28(10)36(32,33)21-25-24-20(23)35-21)16-14(22)7-12-15(18(16)34-2)27(11-3-4-11)9-13(17(12)29)19(30)31/h7,9-11H,3-6,8H2,1-2H3,(H2,23,24)(H,30,31)
- InChIKey
- ZMJSPSHFSJVVKY-UHFFFAOYSA-N
- Compound name
- 7-[4-[(5-amino-1,3,4-thiadiazol-2-yl)sulfonyl]-3-methylpiperazin-1-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 539.11778 | 222.8 |
[M+Na]+ | 561.09972 | 233.0 |
[M-H]- | 537.10322 | 227.3 |
[M+NH4]+ | 556.14432 | 219.7 |
[M+K]+ | 577.07366 | 223.2 |
[M+H-H2O]+ | 521.10776 | 215.6 |
[M+HCOO]- | 583.10870 | 225.1 |
[M+CH3COO]- | 597.12435 | 227.4 |
[M+Na-2H]- | 559.08517 | 219.4 |
[M]+ | 538.10995 | 228.6 |
[M]- | 538.11105 | 228.6 |
Literature stripe
Patent stripe
No patent data available for this compound.